News and Updates

The FDA has approved SKINVIVE by JUVÉDERM for neck rejuvenation. Learn how this hyaluronic acid treatment improves skin smoothness and radiance.

The FDA has expanded the use of belzutifan for advanced renal cell carcinoma. Learn about the clinical trial data, HIF-2α inhibition, and patient outcomes.

USC has launched a new clinical trial to test psilocybin for mental health. Explore how this psychedelic-assisted therapy could redefine psychiatric care.

Discover how strategic collaborations are revolutionizing early-phase clinical research to accelerate the drug development pipeline and improve patient care.

Haryana plans a ₹10,000 crore boost for the Pharma and MedTech sectors. Discover how this move aims to cut import reliance and foster domestic innovation.

The confirmatory trial failure of Zepzelca raises critical questions about the FDA’s Accelerated Approval pathway and the future of lung cancer treatments.

Adaptive DBS shows major potential in treating Parkinson's gait. We analyze why new FDA regulatory endpoints are essential for the future of the technology.

A new study confirms the efficacy of combining selinexor and ruxolitinib for myelofibrosis. Discover how this dual therapy improves patient outcomes.

New clinical trials reveal that preserving beta-cell function is the next frontier in diabetes care, potentially shifting treatment toward total remission.

Europe’s drug development sector faces a decline in R&D and market access. Discover why experts are demanding an overhaul to improve patient care.